nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—ALB—Vandetanib—thyroid cancer	0.054	1	CbGbCtD
Sucralfate—EGF—neck—thyroid cancer	0.03	0.141	CbGeAlD
Sucralfate—PGA5—head—thyroid cancer	0.0299	0.141	CbGeAlD
Sucralfate—EGF—saliva-secreting gland—thyroid cancer	0.0234	0.11	CbGeAlD
Sucralfate—FGG—lymph node—thyroid cancer	0.0184	0.0866	CbGeAlD
Sucralfate—EGF—trachea—thyroid cancer	0.0181	0.0851	CbGeAlD
Sucralfate—FGA—head—thyroid cancer	0.0174	0.0817	CbGeAlD
Sucralfate—FGF2—trachea—thyroid cancer	0.0159	0.075	CbGeAlD
Sucralfate—EGF—thyroid gland—thyroid cancer	0.0143	0.0673	CbGeAlD
Sucralfate—EGF—head—thyroid cancer	0.0127	0.0597	CbGeAlD
Sucralfate—FGF2—thyroid gland—thyroid cancer	0.0126	0.0594	CbGeAlD
Sucralfate—EGF—lymph node—thyroid cancer	0.00888	0.0418	CbGeAlD
Sucralfate—FGF2—lymph node—thyroid cancer	0.00783	0.0369	CbGeAlD
Sucralfate—ALB—lymph node—thyroid cancer	0.00307	0.0144	CbGeAlD
Sucralfate—EGF—Signaling by NGF—KRAS—thyroid cancer	0.000334	0.000456	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—NRAS—thyroid cancer	0.000334	0.000455	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—KRAS—thyroid cancer	0.000333	0.000454	CbGpPWpGaD
Sucralfate—FGF2—Immune System—LGALS3—thyroid cancer	0.000333	0.000454	CbGpPWpGaD
Sucralfate—EGF—Disease—CDK1—thyroid cancer	0.000332	0.000453	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—KRAS—thyroid cancer	0.000332	0.000452	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PRKAR1A—thyroid cancer	0.00033	0.000451	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—KRAS—thyroid cancer	0.00033	0.00045	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	0.000326	0.000445	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—KRAS—thyroid cancer	0.000325	0.000443	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MEN1—thyroid cancer	0.000323	0.00044	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—NRAS—thyroid cancer	0.00032	0.000436	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—HRAS—thyroid cancer	0.000317	0.000432	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—NRG1—thyroid cancer	0.000314	0.000428	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—KRAS—thyroid cancer	0.000311	0.000423	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—KRAS—thyroid cancer	0.000311	0.000423	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—KRAS—thyroid cancer	0.000311	0.000423	CbGpPWpGaD
Sucralfate—FGF2—Disease—TPR—thyroid cancer	0.00031	0.000423	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000308	0.00042	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—thyroid cancer	0.000308	0.00042	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—KRAS—thyroid cancer	0.000308	0.00042	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NRG1—thyroid cancer	0.000305	0.000416	CbGpPWpGaD
Sucralfate—FGF2—Disease—PRKAR1A—thyroid cancer	0.000305	0.000416	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—KRAS—thyroid cancer	0.000305	0.000416	CbGpPWpGaD
Sucralfate—FGA—Disease—BRAF—thyroid cancer	0.000304	0.000414	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—KRAS—thyroid cancer	0.000304	0.000414	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—HRAS—thyroid cancer	0.000303	0.000413	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—thyroid cancer	0.000302	0.000411	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—thyroid cancer	0.000302	0.000411	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—NRG1—thyroid cancer	0.000301	0.000411	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NRG1—thyroid cancer	0.000299	0.000408	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NRG1—thyroid cancer	0.000299	0.000408	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—HRAS—thyroid cancer	0.000298	0.000406	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000298	0.000406	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TCF7L1—thyroid cancer	0.000297	0.000405	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000296	0.000403	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—HRAS—thyroid cancer	0.000294	0.000401	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000292	0.000398	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PTCH1—thyroid cancer	0.000292	0.000398	CbGpPWpGaD
Sucralfate—FGF2—Disease—MEN1—thyroid cancer	0.000292	0.000398	CbGpPWpGaD
Sucralfate—EGF—Immune System—NRG1—thyroid cancer	0.000289	0.000394	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—HRAS—thyroid cancer	0.000288	0.000393	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—HRAS—thyroid cancer	0.000288	0.000393	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—KRAS—thyroid cancer	0.000287	0.000392	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—HRAS—thyroid cancer	0.000285	0.000388	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—HRAS—thyroid cancer	0.000284	0.000387	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—HRAS—thyroid cancer	0.000283	0.000386	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—HRAS—thyroid cancer	0.000282	0.000384	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—HRAS—thyroid cancer	0.000281	0.000382	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—AKT1—thyroid cancer	0.00028	0.000381	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—thyroid cancer	0.000277	0.000377	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—PTEN—thyroid cancer	0.000275	0.000376	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	0.000275	0.000375	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TERT—thyroid cancer	0.000274	0.000374	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TERT—thyroid cancer	0.000269	0.000366	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TERT—thyroid cancer	0.000269	0.000366	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—AKT1—thyroid cancer	0.000267	0.000365	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SST—thyroid cancer	0.000267	0.000364	CbGpPWpGaD
Sucralfate—EGF—Disease—NRG1—thyroid cancer	0.000267	0.000363	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	0.000264	0.00036	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—HRAS—thyroid cancer	0.000264	0.00036	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—HRAS—thyroid cancer	0.000264	0.00036	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—AKT1—thyroid cancer	0.000263	0.000359	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HIF1A—thyroid cancer	0.000262	0.000357	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—HRAS—thyroid cancer	0.000262	0.000357	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—AKT1—thyroid cancer	0.00026	0.000354	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.00026	0.000354	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—PPARG—thyroid cancer	0.000259	0.000354	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—HRAS—thyroid cancer	0.000259	0.000353	CbGpPWpGaD
Sucralfate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000259	0.000353	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—HRAS—thyroid cancer	0.000258	0.000352	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CALCA—thyroid cancer	0.000257	0.00035	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HIF1A—thyroid cancer	0.000257	0.00035	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HIF1A—thyroid cancer	0.000257	0.00035	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MINPP1—thyroid cancer	0.000256	0.000349	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—AKT1—thyroid cancer	0.000255	0.000347	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—AKT1—thyroid cancer	0.000255	0.000347	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—AKT1—thyroid cancer	0.000251	0.000343	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—AKT1—thyroid cancer	0.000251	0.000342	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—AKT1—thyroid cancer	0.00025	0.000341	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—AKT1—thyroid cancer	0.000249	0.000339	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—PTEN—thyroid cancer	0.000248	0.000338	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—AKT1—thyroid cancer	0.000248	0.000338	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—NRAS—thyroid cancer	0.000246	0.000335	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—NRAS—thyroid cancer	0.000246	0.000335	CbGpPWpGaD
Sucralfate—FGA—Disease—PTGS2—thyroid cancer	0.000245	0.000334	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—HRAS—thyroid cancer	0.000244	0.000333	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thyroid cancer	0.000244	0.000333	CbGpPWpGaD
Sucralfate—EGF—Disease—TERT—thyroid cancer	0.000239	0.000326	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—PTEN—thyroid cancer	0.000238	0.000325	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	0.000234	0.000319	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—AKT1—thyroid cancer	0.000233	0.000318	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	0.000233	0.000318	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—AKT1—thyroid cancer	0.000233	0.000318	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CDK1—thyroid cancer	0.000233	0.000317	CbGpPWpGaD
Sucralfate—FGF2—Disease—CALCA—thyroid cancer	0.000232	0.000316	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—AKT1—thyroid cancer	0.000231	0.000315	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PRKAR1A—thyroid cancer	0.00023	0.000313	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—AKT1—thyroid cancer	0.000229	0.000312	CbGpPWpGaD
Sucralfate—EGF—Disease—HIF1A—thyroid cancer	0.000229	0.000312	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—AKT1—thyroid cancer	0.000228	0.000311	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CDK1—thyroid cancer	0.000228	0.00031	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—thyroid cancer	0.000222	0.000302	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—NRAS—thyroid cancer	0.000221	0.000302	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000219	0.000299	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IFNA2—thyroid cancer	0.000219	0.000298	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NDUFA13—thyroid cancer	0.000218	0.000297	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TSHR—thyroid cancer	0.000217	0.000296	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—BRAF—thyroid cancer	0.000217	0.000296	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—AKT1—thyroid cancer	0.000216	0.000294	CbGpPWpGaD
Sucralfate—FGA—Disease—PTEN—thyroid cancer	0.000214	0.000292	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PRKAR1A—thyroid cancer	0.000214	0.000291	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—NRAS—thyroid cancer	0.000213	0.00029	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—BRAF—thyroid cancer	0.000213	0.00029	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—BRAF—thyroid cancer	0.000213	0.00029	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—KRAS—thyroid cancer	0.000212	0.000289	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—KRAS—thyroid cancer	0.000212	0.000288	CbGpPWpGaD
Sucralfate—FGF2—Disease—CDK1—thyroid cancer	0.00021	0.000286	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	0.000206	0.000281	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CHST14—thyroid cancer	0.000205	0.000279	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MEN1—thyroid cancer	0.000204	0.000278	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	0.000202	0.000276	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000202	0.000276	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000199	0.000271	CbGpPWpGaD
Sucralfate—FGA—Disease—NRAS—thyroid cancer	0.000191	0.00026	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—KRAS—thyroid cancer	0.000191	0.00026	CbGpPWpGaD
Sucralfate—EGF—Disease—BRAF—thyroid cancer	0.00019	0.000258	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—thyroid cancer	0.000188	0.000257	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NRG1—thyroid cancer	0.000187	0.000254	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PTCH1—thyroid cancer	0.000185	0.000252	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—KRAS—thyroid cancer	0.000183	0.00025	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NRG1—thyroid cancer	0.000183	0.000249	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—HRAS—thyroid cancer	0.00018	0.000245	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—HRAS—thyroid cancer	0.00018	0.000245	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SST—thyroid cancer	0.000169	0.00023	CbGpPWpGaD
Sucralfate—FGF2—Disease—NRG1—thyroid cancer	0.000169	0.00023	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TERT—thyroid cancer	0.000168	0.000228	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HPGD—thyroid cancer	0.000165	0.000225	CbGpPWpGaD
Sucralfate—FGA—Disease—KRAS—thyroid cancer	0.000164	0.000224	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CALCA—thyroid cancer	0.000163	0.000222	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—HRAS—thyroid cancer	0.000162	0.000221	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HIF1A—thyroid cancer	0.00016	0.000218	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—AKT1—thyroid cancer	0.000159	0.000217	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—AKT1—thyroid cancer	0.000159	0.000216	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—NRAS—thyroid cancer	0.000159	0.000216	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCND1—thyroid cancer	0.000158	0.000216	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PTEN—thyroid cancer	0.000157	0.000214	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HRAS—thyroid cancer	0.000156	0.000212	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCND1—thyroid cancer	0.000155	0.000212	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCND1—thyroid cancer	0.000155	0.000212	CbGpPWpGaD
Sucralfate—EGF—Disease—PTGS2—thyroid cancer	0.000153	0.000209	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PTEN—thyroid cancer	0.000153	0.000208	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IFNA2—thyroid cancer	0.000152	0.000208	CbGpPWpGaD
Sucralfate—FGF2—Disease—TERT—thyroid cancer	0.000151	0.000206	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000151	0.000206	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PTEN—thyroid cancer	0.000151	0.000206	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PTEN—thyroid cancer	0.00015	0.000204	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PTEN—thyroid cancer	0.00015	0.000204	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CDK1—thyroid cancer	0.000147	0.000201	CbGpPWpGaD
Sucralfate—FGF2—Disease—HIF1A—thyroid cancer	0.000145	0.000197	CbGpPWpGaD
Sucralfate—EGF—Immune System—PTEN—thyroid cancer	0.000145	0.000197	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—AKT1—thyroid cancer	0.000143	0.000195	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—NRAS—thyroid cancer	0.00014	0.000191	CbGpPWpGaD
Sucralfate—FGA—Disease—HRAS—thyroid cancer	0.00014	0.00019	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—AKT1—thyroid cancer	0.000137	0.000187	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—KRAS—thyroid cancer	0.000137	0.000186	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NRAS—thyroid cancer	0.000136	0.000186	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—NRAS—thyroid cancer	0.000135	0.000184	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000134	0.000182	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NRAS—thyroid cancer	0.000134	0.000182	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NRAS—thyroid cancer	0.000134	0.000182	CbGpPWpGaD
Sucralfate—EGF—Disease—PTEN—thyroid cancer	0.000134	0.000182	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—BRAF—thyroid cancer	0.000133	0.000181	CbGpPWpGaD
Sucralfate—EGF—Immune System—NRAS—thyroid cancer	0.000129	0.000176	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000127	0.000173	CbGpPWpGaD
Sucralfate—FGA—Disease—AKT1—thyroid cancer	0.000123	0.000168	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—KRAS—thyroid cancer	0.000121	0.000164	CbGpPWpGaD
Sucralfate—FGF2—Disease—BRAF—thyroid cancer	0.00012	0.000164	CbGpPWpGaD
Sucralfate—EGF—Disease—NRAS—thyroid cancer	0.000119	0.000162	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NRG1—thyroid cancer	0.000118	0.000161	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—KRAS—thyroid cancer	0.000117	0.00016	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—HRAS—thyroid cancer	0.000116	0.000158	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—KRAS—thyroid cancer	0.000116	0.000158	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—KRAS—thyroid cancer	0.000115	0.000157	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—KRAS—thyroid cancer	0.000115	0.000157	CbGpPWpGaD
Sucralfate—EGF—Immune System—KRAS—thyroid cancer	0.000111	0.000151	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TERT—thyroid cancer	0.000106	0.000145	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—thyroid cancer	0.000104	0.000142	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—HRAS—thyroid cancer	0.000103	0.00014	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—AKT1—thyroid cancer	0.000103	0.00014	CbGpPWpGaD
Sucralfate—EGF—Disease—KRAS—thyroid cancer	0.000103	0.00014	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—thyroid cancer	0.000102	0.000139	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—thyroid cancer	0.000102	0.000139	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HIF1A—thyroid cancer	0.000101	0.000138	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HRAS—thyroid cancer	9.98e-05	0.000136	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HRAS—thyroid cancer	9.85e-05	0.000134	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HRAS—thyroid cancer	9.78e-05	0.000133	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HRAS—thyroid cancer	9.78e-05	0.000133	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—thyroid cancer	9.69e-05	0.000132	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCND1—thyroid cancer	9.69e-05	0.000132	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TPR—thyroid cancer	9.47e-05	0.000129	CbGpPWpGaD
Sucralfate—EGF—Immune System—HRAS—thyroid cancer	9.44e-05	0.000129	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PTEN—thyroid cancer	9.35e-05	0.000127	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PRKAR1A—thyroid cancer	9.32e-05	0.000127	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PTEN—thyroid cancer	9.15e-05	0.000125	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—AKT1—thyroid cancer	9.05e-05	0.000123	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AKT1—thyroid cancer	8.81e-05	0.00012	CbGpPWpGaD
Sucralfate—EGF—Disease—HRAS—thyroid cancer	8.71e-05	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—AKT1—thyroid cancer	8.69e-05	0.000119	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AKT1—thyroid cancer	8.63e-05	0.000118	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AKT1—thyroid cancer	8.63e-05	0.000118	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTEN—thyroid cancer	8.45e-05	0.000115	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.44e-05	0.000115	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—BRAF—thyroid cancer	8.4e-05	0.000115	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NRAS—thyroid cancer	8.34e-05	0.000114	CbGpPWpGaD
Sucralfate—EGF—Immune System—AKT1—thyroid cancer	8.33e-05	0.000114	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NRAS—thyroid cancer	8.16e-05	0.000111	CbGpPWpGaD
Sucralfate—EGF—Disease—AKT1—thyroid cancer	7.69e-05	0.000105	CbGpPWpGaD
Sucralfate—FGF2—Disease—NRAS—thyroid cancer	7.54e-05	0.000103	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—KRAS—thyroid cancer	7.18e-05	9.79e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	7.11e-05	9.7e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC5A5—thyroid cancer	7.09e-05	9.66e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—KRAS—thyroid cancer	7.03e-05	9.58e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.64e-05	9.06e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—KRAS—thyroid cancer	6.49e-05	8.84e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—thyroid cancer	6.38e-05	8.7e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCND1—thyroid cancer	6.13e-05	8.36e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HRAS—thyroid cancer	6.1e-05	8.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HRAS—thyroid cancer	5.97e-05	8.14e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—RXRA—thyroid cancer	5.96e-05	8.12e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PTEN—thyroid cancer	5.92e-05	8.07e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.79e-05	7.9e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NRAS—thyroid cancer	5.68e-05	7.74e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—HRAS—thyroid cancer	5.51e-05	7.52e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AKT1—thyroid cancer	5.39e-05	7.35e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NRAS—thyroid cancer	5.28e-05	7.2e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—AKT1—thyroid cancer	5.27e-05	7.19e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—KRAS—thyroid cancer	4.89e-05	6.66e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—AKT1—thyroid cancer	4.87e-05	6.64e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KRAS—thyroid cancer	4.54e-05	6.19e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—thyroid cancer	4.34e-05	5.92e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HRAS—thyroid cancer	4.15e-05	5.66e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—thyroid cancer	4.04e-05	5.5e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HRAS—thyroid cancer	3.86e-05	5.26e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PPARG—thyroid cancer	3.76e-05	5.13e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—AKT1—thyroid cancer	3.67e-05	5e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AKT1—thyroid cancer	3.41e-05	4.65e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—thyroid cancer	2.96e-05	4.03e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTEN—thyroid cancer	2.58e-05	3.52e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AKT1—thyroid cancer	1.49e-05	2.03e-05	CbGpPWpGaD
